Under normal nutrient-rich conditions, mTOR is activated to promote anabolic processes such as protein synthesis and inhibit degradative processes such as autophagy, and the dysregulation of mTOR signaling has been observed in neurodegenerative diseases, making autophagy modulators attractive therapeutic agents for disease intervention. This evidence concerns the gene MTOR and neurodegenerative disease.